221 related articles for article (PubMed ID: 24868900)
1. [Refractory hypercalcemia in patient with lung cancer].
Grzywacz A; Dziuk M; Niemczyk S
Pol Merkur Lekarski; 2014 Apr; 36(214):261-4. PubMed ID: 24868900
[TBL] [Abstract][Full Text] [Related]
2. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
Reagan P; Pani A; Rosner MH
Am J Kidney Dis; 2014 Jan; 63(1):141-7. PubMed ID: 24021907
[TBL] [Abstract][Full Text] [Related]
3. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
Rosner MH; Dalkin AC
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
[TBL] [Abstract][Full Text] [Related]
4. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
5. Denosumab for the treatment of bisphosphonate-refractory hypercalcemia.
Boikos SA; Hammers HJ
J Clin Oncol; 2012 Oct; 30(29):e299. PubMed ID: 22949145
[No Abstract] [Full Text] [Related]
6. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
[TBL] [Abstract][Full Text] [Related]
7. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
8. Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
Hu MI; Glezerman I; Leboulleux S; Insogna K; Gucalp R; Misiorowski W; Yu B; Ying W; Jain RK
J Natl Cancer Inst; 2013 Sep; 105(18):1417-20. PubMed ID: 23990665
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcemia of malignancy: pathophysiology and implications for treatment.
Theriault RL
Oncology (Williston Park); 1993 Jan; 7(1):47-50; discussion 52-5. PubMed ID: 8420542
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors.
Kukreja SC; Shevrin DH; Wimbiscus SA; Ebeling PR; Danks JA; Rodda CP; Wood WI; Martin TJ
J Clin Invest; 1988 Nov; 82(5):1798-802. PubMed ID: 2846659
[TBL] [Abstract][Full Text] [Related]
11. [Penile carcinoma with humoral hypercalcemia of malignancy (HHM): a case report].
Sekita N; Furuya Y; Ueda T; Okano T; Ito H; Matsuzaki O
Hinyokika Kiyo; 1999 Jul; 45(7):497-9. PubMed ID: 10466069
[TBL] [Abstract][Full Text] [Related]
12. Malignancy-related hypercalcemia developing on a bisphosphonate but responding to calcitonin.
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
Clin Lung Cancer; 2007 Jul; 8(7):434-5. PubMed ID: 17681097
[TBL] [Abstract][Full Text] [Related]
13. Denosumab in hypercalcemia of malignancy: a case series.
Dietzek A; Connelly K; Cotugno M; Bartel S; McDonnell AM
J Oncol Pharm Pract; 2015 Apr; 21(2):143-7. PubMed ID: 24415364
[TBL] [Abstract][Full Text] [Related]
14. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma.
Takai E; Yano T; Iguchi H; Fukuyama Y; Yokoyama H; Asoh H; Ichinose Y
Cancer; 1996 Oct; 78(7):1384-7. PubMed ID: 8839542
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms and treatment of hypercalcemia of malignancy.
Clines GA
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
[TBL] [Abstract][Full Text] [Related]
16. [Results of thyrocalcitonin mithramycin, and indomethacin treatment of a case of hypercalcemia in tumor of the lung].
Pesce L; Del Torre L; Busolin G; Macaluso S
Arch Monaldi; 1977; 31(2):119-31. PubMed ID: 141246
[No Abstract] [Full Text] [Related]
17. Using denosumab to treat immobilization hypercalcemia in a post-acute care patient.
Booth KA; Hays CI
J Clin Endocrinol Metab; 2014 Oct; 99(10):3531-5. PubMed ID: 25033064
[TBL] [Abstract][Full Text] [Related]
18. Denosumab for management of parathyroid carcinoma-mediated hypercalcemia.
Vellanki P; Lange K; Elaraj D; Kopp PA; El Muayed M
J Clin Endocrinol Metab; 2014 Feb; 99(2):387-90. PubMed ID: 24178790
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma of the pancreas associated with hypercalcemia.
Brayko CM; Doll DC
Gastroenterology; 1982 Dec; 83(6):1297-9. PubMed ID: 7129033
[TBL] [Abstract][Full Text] [Related]
20. [PTHrP and breast cancer].
Devys A; Lortholary A; Audran M
Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
